Short-term reproducibility of a commercial interferon gamma release assay

Clinical and Vaccine Immunology

Volumn 16, Issue 8, 2009, Pages 1170-1175

  Detjen, A K ^a   Loebenberg, L ^a   Grewal, H M S ^b   Stanley, K ^a   Gutschmidt, A ^a   Kruger, C ^a   Du Plessis, N ^a   Kidd, M ^a   Beyers, N ^a   Walzl, G ^a   Hesseling, A C ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; BIOASSAY; BLOOD STORAGE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTERFERON GAMMA RELEASE ASSAY; PRIORITY JOURNAL; REPRODUCIBILITY; TEST RETEST RELIABILITY; TUBERCULOSIS;

ADULT; HUMANS; IMMUNOASSAY; INTERFERON-GAMMA; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY OF RESULTS; SOUTH AFRICA; TUBERCULOSIS; YOUNG ADULT;

EID: 68149172586     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00168-09     Document Type: Article

References (22)

1. Aiken, A. M., P. C. Hill, A. Fox, K. P. McAdam, D. Jackson-Sillah, M. D. Lugos, S. A. Donkor, R. A. Adegbola, and R. H Brookes. 2006. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect. Dis. 6:66.
2. Canadian Tuberculosis Committee. 2008. Updated recommendations on interferon gamma release assays for latent tuberculosis infection. Canada communicable disease report 2008. Public Health Agency of Canada, Ottawa, Canada. http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/.
3. Carrara, S., D. Vincenti, N. Petrosillo, M. Amicosante, E. Girardi, and D. Goletti. 2004. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin. Infect. Dis. 38:754-756.
4. Diel, R., M. Forssbohm, G. Loytved, W. Haas, B. Hauer, D. Maffei, K. Magdorf, A. Nienhaus, H. L. Rieder, T. Schaberg, J. P. Zellweger, and R. Loddenkemper. 2007. Empfehlungen für die Umgebungsuntersuchungen bei Tuberkulose. Pneumologie 61:440-455.
5. Doherty, T. M., A. Demissie, D. Menzies, P. Andersen, G. Rook, A. Zumla, and the VACSEL Study Group. 2005. Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCR. J. Immunol. Methods 298:129-141.
6. Ewer, K., K. A. Millington, J. J. Deeks, L. Alvarez, G. Bryant, and A. Lalvani. 2006. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 174:831-839.
7. Franken, W. P., B. F. Koster, A. W. Bossink, S. F. Thijsen, J. J. Bouwman, J. T. van Dissel, and S. M Arend. 2007. Follow-up study of tuberculosisexposed supermarket customers with negative tuberculin skin test results in association with positive gamma interferon release assay results. Clin. Vaccine Immunol. 14:1239-1241.
8. Haute Autorité de santé. 2006. Test de dété ction de la production d'interferon-γ pour le diagnosis des infection tuberculeuses. Haute Autorité de santé, Saint Denis La Plaine Cedex, France. http://www.has-sante.fr /portail/jcms/c-490559/test-de-detection- de-la-production-difng-interferon -gamma-pour-le-diagnostic-des-infections- tuberculeuses.
9. Higuchi, K., N. Harada, and T. Mori. 2008. Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis. Respirology 13:468-472.
10. Hill, P. C., R. H. Brookes, A. Fox, D. Jackson-Sillah, D. J. Jeffries, M. D. Lugos, S. A. Donkor, I. M. Adetifa, B. C. de Jong, A. M. Aiken, R. A. Adegbola, and K. P. McAdam. 2007. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med. 4:e192.
11. Joshi, R., A. L. Reingold, D. Menzies, and M. Pai. 2006. Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med. 3:e494. (Pubitemid 46026453)
12. Karam, F., F. Mbow, H. Fletcher, C. S. Senghor, K. D. Coulibaly, A. M. LeFevre, N. F. Ngom Gueye, T. Dieye, P. S. Sow, S. Mboup, and C. Lienhardt. 2008. Sensitivity of IFN-γ release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS ONE 3:e1441. (Pubitemid 351248273)
13. Mazurek, G. H., J. Jereb, P. Lobue, M. F. Iademarco, B. Metchock, and A. Vernon. 2005. Guidelines for using QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm. Rep. 54(RR-15):49-55.
14. Menzies, D., M. Pai, and G. Comstock. 2007. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med. 146:340-354.
15. National Institute for Health and Clinical Excellence. 2006. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Clinical guidelines CG33. National Institute for Health and Clinical Excellence, London, United Kingdom. http://www.nice .org.uk/CG033.
16. Pai, M., K. Gokhale, R. Joshi, S. Dogra, S. Kalantri, D. K. Mendiratta, P. Narang, C. L. Daley, R. M. Granich, G. H. Mazurek, A. L. Reingold, L. W. Riley, and J. M. Colford, Jr. 2005. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 293:2746-2755.
17. Pai, M., R. Joshi, S. Dogra, D. K. Mendiratta, P. Narang, S. Kalantri, A. L. Reingold, J. M. Colford, Jr., L. W. Riley, and D. Menzies. 2006. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am. J. Respir. Crit. Care Med. 174:349-355.
18. Pai, M., and R. O'Brien. 2007. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med. 4:e208.
19. Pai, M., A. Zwerling, and D. Menzies. 2008. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med. 149:177-184.
20. Perry, S., L. Sanchez, S. Yang, Z. Agarwal, P. Hurst, and J. Parsonnet. 2008. Reproducibility of QuantiFERON-TB Gold in-tube assay. Clin. Vaccine Immunol. 15:425-432.
21. Rangaka, M. X., L. Diwakar, R. Seldon, G. van Cutsem, G. A. Meintjes. C. Morroni, P. Mouton, M. S. Shey, G. Maartens, K. A. Wilkinson, and R. J. Wilkinson. 2007. Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans. Clin. Infect. Dis. 44:1639-1646.
22. Veerapathran, A., R. Joshi, K. Goswami, S. Dogra, E. E. Moodie, M. V. Reddy, S. Kalantri, K. Schwartzman, M. A. Behr, D. Menzies, and M. Pai. 2008. T-cell assays for tuberculosis infection: deriving cutoffs for conversions using reproducibility data. PLoS ONE. 3:e1850. (Pubitemid 351936464)